Renal Cancer - Results from #3260

Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients. October 15, 2019

Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma. October 15, 2019

Study on the mechanism and intervention strategy of sunitinib induced nephrotoxicity. October 14, 2019

Automated clear cell renal carcinoma grade classification with prognostic significance. October 14, 2019

Renal Cell Carcinoma: the Oncologist Asks, Can PSMA PET/CT Answer? October 14, 2019

Microwave Thermal Ablation versus Open Partial Nephrectomy for the Treatment of Small Renal Tumors in Patients Over 70 Years Old. October 11, 2019

The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort. October 11, 2019

Radiogenomics in Clear Cell Renal Cell Carcinoma: Correlations Between Advanced CT Imaging (Texture Analysis) and MicroRNAs Expression. October 11, 2019

Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated with either Percutaneous Microwave Ablation or Surgery. October 10, 2019

Dual inhibition of angiopoietin-TIE2 and MET alters the tumor microenvironment and prolongs survival in a metastatic model of renal cell carcinoma. October 10, 2019

Sunitinib First-line Treatment in Metastatic Renal Cell Carcinoma: Costs and Effects. October 10, 2019

miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer. October 9, 2019

Predictive value of preoperative neutrophil-to-lymphocyte ratio in non-metastatic papillary renal cell carcinoma patients after receiving curative surgery. October 9, 2019

First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis. October 9, 2019

Perioperative outcomes in elderly patients undergoing nephrectomy for renal cell carcinoma. October 8, 2019

Metastatic clear cell renal cell carcinoma to the forearm without identifiable primary renal mass. October 8, 2019

The Role of Pazopanib in Non-Clear Cell Renal Cell Carcinoma: A Systematic Review. October 8, 2019

Renal Cell Carcinoma Follow-Up - Is it Time to Abandon Ultrasound? October 7, 2019

Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: How to Apply New Evidence in Clinical Practice. October 7, 2019

Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma. October 7, 2019

Page 164 of 456